- Smiths Interconnect provides mission-critical components to the $5B aerospace and defense sector, as well as semiconductor test, industrial and medical markets
- Smiths Interconnect’s leadership in providing innovative medical interconnect solutions complements Molex’s position in the rapidly expanding medtech segment
- Customers and partners to benefit from combined engineering expertise, expanded technology portfolio and enhanced global footprint
Molex, a leading global electronics connectivity innovator, today announced that it has signed an agreement to acquire Smiths Interconnect. Smiths Interconnect, a subsidiary of United Kingdom-based Smiths Group plc, is a leading provider of high-reliability connectivity products and solutions serving the aerospace and defense, medical, semiconductor test and industrial markets. Smiths will receive cash consideration for the transaction, subject to customary adjustments for working capital, cash and debt.
Credit: Michael Vi / Shutterstock
“Molex is excited to reinforce our commitment to the aerospace and defense market with the acquisition of Smiths Interconnect,” said Joe Nelligan, CEO, Molex. “Smiths Interconnect has a highly complementary portfolio of advantaged solutions that strongly enhances the platform established by our acquisition of AirBorn last November. The combination of Molex’s global scale, capabilities and financial stability with Smiths Interconnect’s complementary technologies, products, customers and footprint will enable us to expand our aerospace and defense business and support customers in new and innovative ways.”
Smiths Interconnect designs and manufactures technically differentiated electronic components, along with microwave, optical and radio frequency products and subsystems that connect, protect and control critical applications. Smiths Interconnect has 21 sales, R&D and manufacturing locations across 12 countries, including the United States, Canada, Mexico, Costa Rica, France, Germany, Italy, the United Kingdom, Tunisia, India, China and Singapore.
The acquisition is expected to close in the first half of 2026, subject to regulatory approvals and other customary closing conditions. More information will be shared at that time. Jones Day is acting as Molex’s legal advisor and Rothschild & Co is serving as Molex’s exclusive financial advisor.